Clinical Trials for Triple Negative Breast Cancer

Find clinical trials for triple negative breast cancer. Discover research opportunities and treatment options in your area.

159 Active Trials Found

Showing 159 trials on this page

Page 8 of 8

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

NCT ID: NCT05806385

The LOGIC clinical trial is studying a new treatment approach for women with triple negative breast cancer, which is a more aggressive form of the disease. This trial aims to combine two methods: c...

Not yet recruiting

Phase: PHASE1 Type: interventional

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

NCT ID: NCT05296564

This clinical trial is studying a new treatment called HBI 0201-ESO TCR-Gene Engineered Lymphocytes, which is designed to help patients with certain types of metastatic cancers that express a prote...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jerusalem, , Israel

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer

NCT ID: NCT05491083

This clinical trial is testing a new treatment for patients with advanced solid tumors, particularly focusing on those with triple-negative breast cancer (TNBC). The study is exploring the safety a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Singapore, , Singapore

Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform

NCT ID: NCT05916755

This clinical trial is looking to improve treatment for patients with triple-negative breast cancer (TNBC), a type of breast cancer that does not respond to certain hormone therapies. The study wil...

Recruiting

Type: observational Locations: Barcelona, , Spain

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

NCT ID: NCT05910710

This clinical trial is studying how a medication called pembrolizumab affects patients with triple negative breast cancer who are receiving a specific type of chemotherapy before surgery. The resea...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of

Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

NCT ID: NCT05447702

This clinical trial is investigating a new treatment approach for women with triple negative breast cancer (TNBC), a type of breast cancer that does not have certain hormone receptors and tends to ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chengdu, Sichuan, China

Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial

NCT ID: NCT05763992

The BREAKFAST 2 Trial is studying a new approach to treat women with a specific type of breast cancer called Triple Negative Breast Cancer (TNBC) before surgery. This trial aims to see if combining...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milan, , Italy

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

NCT ID: NCT05769491

This clinical trial is focused on understanding the experiences of women with Triple Negative Breast Cancer when it comes to participating in medical research. The study aims to uncover the challen...

Not yet recruiting

Type: observational

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

NCT ID: NCT03475953

This clinical trial is testing a combination of two medications, Regorafenib and Avelumab, to see how well they work together in treating patients with advanced solid tumors, including various type...

Recruiting

Phase: PHASE1 Type: interventional Locations: Villejuif, , France, Lyon, , France +8 more

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

NCT ID: NCT05692661

This clinical trial is looking at a new way to treat certain types of early breast cancer, specifically HER2-positive and triple-negative breast cancer, after surgery. Standard treatment usually in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer

NCT ID: NCT05329532

This clinical trial is studying a new vaccine called Modi-1, which is being tested to see how safe and effective it is for patients with certain types of advanced cancers, including triple negative...

Recruiting

Phase: PHASE1 Type: interventional Locations: Brighton, Default, United Kingdom, Bristol, Default, United Kingdom +12 more

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

NCT ID: NCT05627960

This clinical trial is investigating a new treatment called AG01, which is an antibody designed to target specific proteins (PGRN/GP88) found on certain cancer cells. It is focused on patients with...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

NCT ID: NCT05461690

This clinical trial is studying a medication called niraparib for women with metastatic triple negative breast cancer (TNBC) that has a specific problem called homologous recombination deficiency (...

Not yet recruiting

Phase: PHASE2 Type: interventional

Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature

NCT ID: NCT05288127

This clinical trial is studying a medication called talazoparib (also known as Talzenna) for women with a specific type of breast cancer known as metastatic triple-negative breast cancer. The trial...

Recruiting

Phase: PHASE2 Type: interventional Locations: Kuala Lumpur, , Malaysia, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

NCT ID: NCT04907344

This clinical trial is studying a new treatment approach for women with triple negative breast cancer (TNBC), a type of breast cancer that does not respond to certain hormones or proteins. The tria...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China, Tianjin, Tianjin, China

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

NCT ID: NCT04437160

This clinical trial is studying the effectiveness and safety of a specific type of chemotherapy called anthracycline-based treatment for patients with triple negative breast cancer (TNBC) who still...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)

NCT ID: NCT04301739

This clinical trial is studying a new treatment called HLX10, which is being tested alongside standard chemotherapy for women with triple-negative breast cancer (TNBC) that has not spread to other ...

Not yet recruiting

Phase: PHASE3 Type: interventional

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT ID: NCT04225858

This clinical trial is looking at whether some women with breast cancer can skip a specific procedure called sentinel lymph node biopsy (SLNB) after receiving chemotherapy. The study focuses on wom...

Not yet recruiting

Phase: NA Type: interventional

Huaier Granule in Treating Women With Triple Negative Breast Cancer

NCT ID: NCT02615457

This clinical trial is studying the effects of a traditional Chinese medicine called Huaier Granule in treating women with triple negative breast cancer, which is a type of breast cancer that doesn...

Recruiting

Phase: PHASE4 Type: interventional Locations: Ji'nan, Shandong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions